[Treatment of urinary tract infections in paralytics with spinal cord lesions. Effect and tolerance of co-soltrim (lidaprim)].
Lidaprim, a bactericidal chemotherapeutical substance (combination of sulfametrol and trimethoprim), was administered to 29 patients with transverse lesions of the cord with paraplegia and urinary tract infections. The substance was tested in view to its antibacterial activity and its tolerance. Concerning therapeutic effects and tolerance the results were noteworthy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D001437:Bacteriuria / Q000188:drug therapy; D004334:Drug Administration Schedule; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010243:Paralysis / Q000150:complications*; D013119:Spinal Cord Injuries / Q000150:complications*; D013424:Sulfanilamides / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D013424:Sulfanilamides; C011900:lidaprim; D014295:Trimethoprim
Behandlung von Harnwegsinfektionen bei Querschnittsgelähmten. Zur Wirkung und Verträglichkeit von Co-soltrim (Lidaprim).